A Phase 3, Open-Label Extension Study of Tirasemtiv for Patients with Amyotrophic Lateral Sclerosis (ALS) Who Completed VITALITY -ALS (CY 4031)
Administered By
Awarded By
Contributors
- Bedlack, Richard Stanley Principal Investigator
Start/End
- December 1, 2016 - April 13, 2018